127 related articles for article (PubMed ID: 28239789)
1. Impairment of Energy-Dependent Processes in the Muscle Tissue as a Pathogenetic Mechanism of Statin-Induced Myopathy.
Mikashinovich ZI; Belousova ES; Sarkisyan OG
Bull Exp Biol Med; 2017 Feb; 162(4):433-435. PubMed ID: 28239789
[TBL] [Abstract][Full Text] [Related]
2. Sporadic rippling muscle disease unmasked by simvastatin.
Baker SK; Tarnopolsky MA
Muscle Nerve; 2006 Oct; 34(4):478-81. PubMed ID: 16688722
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes.
Kwak HB; Thalacker-Mercer A; Anderson EJ; Lin CT; Kane DA; Lee NS; Cortright RN; Bamman MM; Neufer PD
Free Radic Biol Med; 2012 Jan; 52(1):198-207. PubMed ID: 22080086
[TBL] [Abstract][Full Text] [Related]
4. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
Duncan AJ; Hargreaves IP; Damian MS; Land JM; Heales SJ
Toxicol Mech Methods; 2009 Jan; 19(1):44-50. PubMed ID: 19778232
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats.
Ghalwash M; Elmasry A; El-Adeeb N
J Basic Clin Physiol Pharmacol; 2018 Sep; 29(5):483-491. PubMed ID: 29584613
[No Abstract] [Full Text] [Related]
6. Myopathy secondary to simvastatin in a type 2 diabetic patient.
Udawat H; Goyal RK
J Assoc Physicians India; 2002 Mar; 50():439-40. PubMed ID: 11922239
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles.
Simsek Ozek N; Bal IB; Sara Y; Onur R; Severcan F
Biochim Biophys Acta; 2014 Jan; 1840(1):406-15. PubMed ID: 24045089
[TBL] [Abstract][Full Text] [Related]
8. Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.
Dorajoo Rs; Pereira BP; Yu Z; Gopalakrishnakone P; Leong CC; Wee A; Lee E
Life Sci; 2008 Apr; 82(15-16):823-30. PubMed ID: 18509883
[TBL] [Abstract][Full Text] [Related]
9. Statin induced myopathy.
Frank RE
J Insur Med; 2009; 41(2):132-5. PubMed ID: 19845216
[TBL] [Abstract][Full Text] [Related]
10. Statins Trigger Mitochondrial Reactive Oxygen Species-Induced Apoptosis in Glycolytic Skeletal Muscle.
Bouitbir J; Singh F; Charles AL; Schlagowski AI; Bonifacio A; Echaniz-Laguna A; Geny B; Krähenbühl S; Zoll J
Antioxid Redox Signal; 2016 Jan; 24(2):84-98. PubMed ID: 26414931
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats.
Javadov S; Jang S; Rodriguez-Reyes N; Rodriguez-Zayas AE; Soto Hernandez J; Krainz T; Wipf P; Frontera W
Oncotarget; 2015 Nov; 6(37):39469-81. PubMed ID: 26415224
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D supplementation rescues simvastatin induced myopathy in mice via improving mitochondrial cristae shape.
Ren L; Xuan L; Han F; Zhang J; Gong L; Lv Y; Zhang W; Yang S; Xu B; Yan Y; Guo L; Liu H; Wan Z; Liu L
Toxicol Appl Pharmacol; 2020 Aug; 401():115076. PubMed ID: 32479918
[TBL] [Abstract][Full Text] [Related]
13. The role of mitochondria in statin-induced myopathy.
Apostolopoulou M; Corsini A; Roden M
Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
[TBL] [Abstract][Full Text] [Related]
14. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
Fung EC; Crook MA
Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin induces impairment in skeletal muscle while heart is protected.
Sirvent P; Bordenave S; Vermaelen M; Roels B; Vassort G; Mercier J; Raynaud E; Lacampagne A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1426-34. PubMed ID: 16271704
[TBL] [Abstract][Full Text] [Related]
16. The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity.
Bonifacio A; Sanvee GM; Bouitbir J; Krähenbühl S
Biochim Biophys Acta; 2015 Aug; 1853(8):1841-9. PubMed ID: 25913013
[TBL] [Abstract][Full Text] [Related]
17. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.
Laaksonen R; Katajamaa M; Päivä H; Sysi-Aho M; Saarinen L; Junni P; Lütjohann D; Smet J; Van Coster R; Seppänen-Laakso T; Lehtimäki T; Soini J; Oresic M
PLoS One; 2006 Dec; 1(1):e97. PubMed ID: 17183729
[TBL] [Abstract][Full Text] [Related]
18. Myopathy during treatment with the antianginal drug ranolazine.
Kassardjian CD; Tian X; Vladutiu G; Wong LJ; Milone M
J Neurol Sci; 2014 Dec; 347(1-2):380-2. PubMed ID: 25466697
[TBL] [Abstract][Full Text] [Related]
19. Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.
Min K; Kwon OS; Smuder AJ; Wiggs MP; Sollanek KJ; Christou DD; Yoo JK; Hwang MH; Szeto HH; Kavazis AN; Powers SK
J Physiol; 2015 Apr; 593(8):2017-36. PubMed ID: 25643692
[TBL] [Abstract][Full Text] [Related]
20. At environmental doses, dietary methylmercury inhibits mitochondrial energy metabolism in skeletal muscles of the zebra fish (Danio rerio).
Cambier S; Bénard G; Mesmer-Dudons N; Gonzalez P; Rossignol R; Brèthes D; Bourdineaud JP
Int J Biochem Cell Biol; 2009 Apr; 41(4):791-9. PubMed ID: 18765295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
